Sartorius Acquires Cellca

News   Jul 03, 2015

 
Sartorius Acquires Cellca
 
 
 

RELATED ARTICLES

Reprogrammed Virus Offers Hope as Cancer Treatment

News

A cancer treatment that can completely destroy cancer cells without affecting healthy cells could soon be a possibility. The team of researchers has successfully ‘trained’ a respiratory virus to recognise ovarian cancer and completely destroy it without infecting other cells. The reprogrammed virus could also be used to treat other cancers such as breast, pancreatic, lung and oral.

READ MORE

Bicycle Therapeutics Expands Strategic Partnership with AstraZeneca

News

New programs added in respiratory and cardio-metabolic diseases.

READ MORE

Worldwide Clinical Trials Receives 2018 CRO Leadership Awards

News

Life Science Leader and Industry Standard Research assess 70 contract research organizations, honoring Worldwide Clinical Trials for fifth consecutive year.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy